1. Home
  2. ABCL vs IART Comparison

ABCL vs IART Comparison

Compare ABCL & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • IART
  • Stock Information
  • Founded
  • ABCL 2012
  • IART 1989
  • Country
  • ABCL Canada
  • IART United States
  • Employees
  • ABCL N/A
  • IART N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • IART Medical/Dental Instruments
  • Sector
  • ABCL Health Care
  • IART Health Care
  • Exchange
  • ABCL Nasdaq
  • IART Nasdaq
  • Market Cap
  • ABCL 1.1B
  • IART 1.2B
  • IPO Year
  • ABCL 2020
  • IART 1995
  • Fundamental
  • Price
  • ABCL $3.90
  • IART $12.01
  • Analyst Decision
  • ABCL Buy
  • IART Hold
  • Analyst Count
  • ABCL 5
  • IART 7
  • Target Price
  • ABCL $7.75
  • IART $15.00
  • AVG Volume (30 Days)
  • ABCL 4.9M
  • IART 1.3M
  • Earning Date
  • ABCL 11-06-2025
  • IART 10-30-2025
  • Dividend Yield
  • ABCL N/A
  • IART N/A
  • EPS Growth
  • ABCL N/A
  • IART N/A
  • EPS
  • ABCL N/A
  • IART N/A
  • Revenue
  • ABCL $35,325,000.00
  • IART $1,642,966,000.00
  • Revenue This Year
  • ABCL $16.99
  • IART $3.51
  • Revenue Next Year
  • ABCL $62.91
  • IART $2.88
  • P/E Ratio
  • ABCL N/A
  • IART N/A
  • Revenue Growth
  • ABCL 7.17
  • IART 4.99
  • 52 Week Low
  • ABCL $1.89
  • IART $10.87
  • 52 Week High
  • ABCL $6.52
  • IART $27.13
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 28.38
  • IART 38.31
  • Support Level
  • ABCL $5.35
  • IART $10.87
  • Resistance Level
  • ABCL $5.68
  • IART $16.42
  • Average True Range (ATR)
  • ABCL 0.32
  • IART 0.87
  • MACD
  • ABCL -0.21
  • IART -0.40
  • Stochastic Oscillator
  • ABCL 17.84
  • IART 20.45

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Share on Social Networks: